Bladder Cancer Takes Center Stage With Breakthrough Advancements at AUA 2025
IN THIS INTERVIEW: MIU’s Chief Medical Officer and Director of Clinical Research, Jason Hafron, M.D., shares what he believes are some of the most exciting parts of this year’s American Urological Association conference: the bladder cancer presentations—specifically, updates on non-muscle-invasive bladder cancer trials that have been ongoing over the last few years.
